Y-90 Ibritumomab Tiuxetan (Zevalin (R)) Consolidation of First Remission In Advanced Stage Follicular Non Hodgkin's Lymphoma Updated Results After a Median Follow up of 662 Months From the International, Randomized, Phase III First Line Indolent Trial (FIT) In 414 Patients
Hagenbeek A., Radford J., Van Hoof A., Vitolo U., Rohatiner A. Z.S., Salles G., Soubeyran P., Tilly H., Delaloye A.B., van Putten W. L.J. et al., 2010. pp. 261-262 dans 52nd Annual Meeting of the American-Society-of-Hematology, Blood. Peer-reviewed.
ici le détail